Literature DB >> 33542717

Membrane Interactome of a Recombinant Fragment of Human Surfactant Protein D Reveals GRP78 as a Novel Binding Partner in PC3, a Metastatic Prostate Cancer Cell Line.

Gargi Thakur1, Gajanan Sathe2,3, Indra Kundu4, Barnali Biswas1, Poonam Gautam5, Saad Alkahtani6, Susan Idicula-Thomas4, Ravi Sirdeshmukh2,3, Uday Kishore7, Taruna Madan1.   

Abstract

Surfactant protein-D (SP-D), a member of the collectin family has been shown to induce apoptosis in cancer cells. SP-D is composed of an N-terminal collagen-like domain and a calcium-dependent carbohydrate recognition domain (CRD). Recently, we reported that a recombinant fragment of human SP-D (rfhSP-D), composed of homotrimeric CRD region, induced intrinsic apoptotic pathway in prostate cancer cells. Here, we analyzed the membrane interactome of rfhSP-D in an androgen-independent prostate cancer cell line, PC3, by high resolution mass spectrometry and identified 347 proteins. Computational analysis of PPI network of this interactome in the context of prostate cancer metastasis and apoptosis revealed Glucose Regulated Protein of 78 kDa (GRP78) as an important binding partner of rfhSP-D. Docking studies suggested that rfhSP-D (CRD) bound to the substrate-binding domain of glycosylated GRP78. This was further supported by the observations that human recombinant GRP78 interfered with the binding of rfhSP-D to anti-SP-D polyclonal antibodies; GRP78 also significantly inhibited the binding of recombinant full-length human SP-D with a monoclonal antibody specific to the CRD in a dose-dependent manner. We conclude that the interaction with rfhSP-D is likely to interfere with the pro-survival signaling of GRP78.
Copyright © 2021 Thakur, Sathe, Kundu, Biswas, Gautam, Alkahtani, Idicula-Thomas, Sirdeshmukh, Kishore and Madan.

Entities:  

Keywords:  GRP78; apoptosis; innate immunity; interactome analysis; prostate cancer; signaling; surfactant protein D

Mesh:

Substances:

Year:  2021        PMID: 33542717      PMCID: PMC7850985          DOI: 10.3389/fimmu.2020.600660

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  73 in total

1.  Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function.

Authors:  Bong Kyung Shin; Hong Wang; Anne Marie Yim; Francois Le Naour; Franck Brichory; Jun Ho Jang; Rong Zhao; Eric Puravs; John Tra; Claire W Michael; David E Misek; Samir M Hanash
Journal:  J Biol Chem       Date:  2002-12-18       Impact factor: 5.157

2.  Proteomics. Tissue-based map of the human proteome.

Authors:  Mathias Uhlén; Linn Fagerberg; Björn M Hallström; Cecilia Lindskog; Per Oksvold; Adil Mardinoglu; Åsa Sivertsson; Caroline Kampf; Evelina Sjöstedt; Anna Asplund; IngMarie Olsson; Karolina Edlund; Emma Lundberg; Sanjay Navani; Cristina Al-Khalili Szigyarto; Jacob Odeberg; Dijana Djureinovic; Jenny Ottosson Takanen; Sophia Hober; Tove Alm; Per-Henrik Edqvist; Holger Berling; Hanna Tegel; Jan Mulder; Johan Rockberg; Peter Nilsson; Jochen M Schwenk; Marica Hamsten; Kalle von Feilitzen; Mattias Forsberg; Lukas Persson; Fredric Johansson; Martin Zwahlen; Gunnar von Heijne; Jens Nielsen; Fredrik Pontén
Journal:  Science       Date:  2015-01-23       Impact factor: 47.728

3.  Surfactant protein D suppresses lung cancer progression by downregulation of epidermal growth factor signaling.

Authors:  Y Hasegawa; M Takahashi; S Ariki; D Asakawa; M Tajiri; Y Wada; Y Yamaguchi; C Nishitani; R Takamiya; A Saito; Y Uehara; J Hashimoto; Y Kurimura; H Takahashi; Y Kuroki
Journal:  Oncogene       Date:  2014-03-10       Impact factor: 9.867

4.  Extracellular Hsp90 mediates an NF-κB dependent inflammatory stromal program: implications for the prostate tumor microenvironment.

Authors:  J E Bohonowych; M W Hance; K D Nolan; M Defee; C H Parsons; J S Isaacs
Journal:  Prostate       Date:  2013-12-16       Impact factor: 4.104

5.  Functional characterization of the different oligomeric forms of human surfactant protein SP-D.

Authors:  Raquel Arroyo; Mercedes Echaide; Fernando Moreno-Herrero; Jesus Perez-Gil; Paul S Kingma
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2020-04-20       Impact factor: 3.036

Review 6.  Collections and ficolins: humoral lectins of the innate immune defense.

Authors:  Uffe Holmskov; Steffen Thiel; Jens C Jensenius
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

7.  HSP70s: From Tumor Transformation to Cancer Therapy.

Authors:  Chih-Wen Shu; Chun-Ming Huang
Journal:  Clin Med Oncol       Date:  2008-04-24

8.  The interaction between SPARC and GRP78 interferes with ER stress signaling and potentiates apoptosis via PERK/eIF2α and IRE1α/XBP-1 in colorectal cancer.

Authors:  Yi-Jye Chern; John C T Wong; Grace S W Cheng; Angel Yu; Yaling Yin; David F Schaeffer; Hagen F Kennecke; Gregg Morin; Isabella T Tai
Journal:  Cell Death Dis       Date:  2019-06-26       Impact factor: 8.469

9.  The DisGeNET knowledge platform for disease genomics: 2019 update.

Authors:  Janet Piñero; Juan Manuel Ramírez-Anguita; Josep Saüch-Pitarch; Francesco Ronzano; Emilio Centeno; Ferran Sanz; Laura I Furlong
Journal:  Nucleic Acids Res       Date:  2020-01-08       Impact factor: 16.971

10.  Upregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patients.

Authors:  Rong Biaoxue; Jiang Xiling; Yang Shuanying; Zhang Wei; Cai Xiguang; Wang Jinsui; Zhang Min
Journal:  J Exp Clin Cancer Res       Date:  2012-08-28
View more
  2 in total

1.  In silico study reveals binding potential of rotenone at multiple sites of pulmonary surfactant proteins: A matter of concern.

Authors:  Prem Rajak; Sumedha Roy; Achintya Kumar Pal; Manas Paramanik; Moumita Dutta; Sayanti Podder; Saurabh Sarkar; Abhratanu Ganguly; Moutushi Mandi; Anik Dutta; Kanchana Das; Siddhartha Ghanty; Salma Khatun
Journal:  Curr Res Toxicol       Date:  2021-12-04

2.  Immunomodulatory Role of Surfactant Protein-D in a Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) Model.

Authors:  Kasturi Ganguly; Uday Kishore; Siddhanath M Metkari; Taruna Madan
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.